Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan flag Japan · Delayed Price · Currency is JPY
2,654.00
+23.00 (0.87%)
May 9, 2025, 3:30 PM JST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Pharmaceutical
227.93B
Log In
Log In
Log In
Log In
Pharmaceutical Growth
9.13%
Log In
Log In
Log In
Log In
Finished Goods - Cardiovascular System and Respiratory Medicine
-
Log In
Log In
Log In
Log In
Finished Goods - Cardiovascular System and Respiratory Medicine Growth
-
Log In
Log In
Log In
Log In
Finished Goods - Drugs for Nervous System and Allergies
-
Log In
Log In
Log In
Log In
Finished Goods - Drugs for Nervous System and Allergies Growth
-
Log In
Log In
Log In
Log In
Finished Goods - Drugs for Gastrointestinal
-
Log In
Log In
Log In
Log In
Finished Goods - Drugs for Gastrointestinal Growth
-
Log In
Log In
Log In
Log In
Finished Goods - Other
-
Log In
Log In
Log In
Log In
Finished Goods - Other Growth
-
Log In
Log In
Log In
Log In
Finished Goods - Other Metabolic Drug
-
Log In
Log In
Log In
Log In
Finished Goods - Other Metabolic Drug Growth
-
Log In
Log In
Log In
Log In
Finished Goods - Antibiotics and Chemotherapeutic Agents
-
Log In
Log In
Log In
Log In
Finished Goods - Antibiotics and Chemotherapeutic Agents Growth
-
Log In
Log In
Log In
Log In
Finished Goods - Vitamins Pills
-
Log In
Log In
Log In
Log In
Finished Goods - Vitamins Pills Growth
-
Log In
Log In
Log In
Log In
Merchandise - Drugs for Nervous System and Allergies
-
Log In
Log In
Log In
Log In
Merchandise - Drugs for Nervous System and Allergies Growth
-
Log In
Log In
Log In
Log In
Finished Goods - Hormone Agent
-
Log In
Log In
Log In
Log In
Other
-
Log In
Log In
Log In
Log In
Other Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Japan
178.72B
Log In
Log In
Log In
Log In
Japan Growth
14.90%
Log In
Log In
Log In
Log In
Overseas
49.22B
Log In
Log In
Log In
Log In
Overseas Growth
-7.69%
Log In
Log In
Log In
Log In